You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
AstraZeneca
Harvard Business School
Colorcon
Express Scripts

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Carbidopa - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for carbidopa and what is the scope of patent protection?

Carbidopa is the generic ingredient in sixteen branded drugs marketed by Alvogen, Ani Pharms Inc, Aurobindo Pharma Ltd, Edenbridge Pharms, Novel Labs Inc, Zydus Pharms, Aton, Sun Pharm, Wockhardt Ltd, Orion Pharma, Impax Labs Inc, Abbvie Inc, Accord Hlthcare, Alembic Pharms Ltd, Apotex, Impax Labs, Kv Pharm, Mylan, Sun Pharm Inds, Merck Sharp Dohme, Ranbaxy, Ucb Inc, Actavis Elizabeth, Apotex Inc, Mayne Pharma, SCS, and Watson Labs, and is included in thirty-nine NDAs. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for carbidopa. Thirteen suppliers are listed for this compound.

Drug Prices for carbidopa

See drug prices for carbidopa

Recent Clinical Trials for carbidopa

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lawson Health Research InstitutePhase 1/Phase 2
Vanderbilt University Medical CenterPhase 1
University of MichiganPhase 1/Phase 2

See all carbidopa clinical trials

Medical Subject Heading (MeSH) Categories for carbidopa

US Patents and Regulatory Information for carbidopa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orion Pharma STALEVO 200 carbidopa; entacapone; levodopa TABLET;ORAL 021485-004 Aug 2, 2007 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-002 Jan 7, 2015 RX Yes No   Start Trial   Start Trial Y   Start Trial
Orion Pharma STALEVO 100 carbidopa; entacapone; levodopa TABLET;ORAL 021485-002 Jun 11, 2003 AB RX Yes No   Start Trial   Start Trial Y   Start Trial
Apotex CARBIDOPA AND LEVODOPA carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 076212-001 Jun 16, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Ranbaxy CARBILEV carbidopa; levodopa TABLET, FOR SUSPENSION;ORAL 076643-003 Jun 10, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs Inc RYTARY carbidopa; levodopa CAPSULE, EXTENDED RELEASE;ORAL 203312-003 Jan 7, 2015 RX Yes No   Start Trial   Start Trial Y   Start Trial
Zydus Pharms CARBIDOPA carbidopa TABLET;ORAL 209910-001 May 7, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for carbidopa

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Aton LODOSYN carbidopa TABLET;ORAL 017830-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Johnson and Johnson
McKinsey
Harvard Business School
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.